Skip to main content
Clinical Trials/NCT07129122
NCT07129122CompletedNot Applicable

A Novel Technique for Percutaneous Mitral Paravalvular Leak Closure: LBBAP Lead Assisted Ventricular Septal Way

Bursa Postgraduate Hospital1 site in 1 country1 target enrollmentStarted: July 31, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
1
Locations
1
Primary Endpoint
mitral paravalvüler leak closure sucsess

Study Overview

Brief Summary

The investigators will perform closure the mitral paravalvular leak in patient with mechanical aortic and mitral valve.

Detailed Description

The mitral mitral paravalvular leak closure access are left atrial and transapical in patient with mechanical aortic and mitral valve.

In this case the investigators will use interventricular septal access.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Had mitral paravalvüler leak Had mitral and aortic mechanical valve

Exclusion Criteria

  • Not suitable for left subclavian access Active infection

Outcomes

Primary Outcomes

mitral paravalvüler leak closure sucsess

Time Frame: 2 day

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hasan ARI

Professor Doctor

Bursa Postgraduate Hospital

Study Sites (1)

Loading locations...

Similar Trials